Usability and Acceptability of a Videoconference Program for the Treatment of Depression in Adults With Peripheral Neuropathy
-
Published:2023-01-31
Issue:10
Volume:41
Page:746-751
-
ISSN:1538-9774
-
Container-title:CIN: Computers, Informatics, Nursing
-
language:en
-
Short-container-title:
Author:
Decker Veronica,King Christian,Cassisi Jeffrey,Tofthagen Cindy
Abstract
Peripheral neuropathy is a debilitating neurological disorder affecting 13% to 14% of the US population. Estimates for co-occurring mood disorders in individuals with neuropathy range from 30% to 47%, but sparse evidence exists regarding depression treatment for adults with neuropathy. A cognitive-behavioral treatment, Acceptance and commitment therapy, is known to reduce depression in people with chronic pain, but little is known about its effectiveness in adults with neuropathy, particularly when the treatment is provided via videoconference. Acceptability and usability of this therapeutic treatment provided via videoconference was assessed in participants with peripheral neuropathy and symptoms of depression. Participants completed pre- and post-self-report outcome measures: the nine-item depression scale of the Patient Health Questionnaire and the 36-item Short-Form Health Survey. They also completed the Acceptability e-Scale and Post-Study System Usability Questionnaire after treatment. Depression decreased significantly, with scores declining from an average of 9.2 to 5.1 on the Patient Health Questionnaire (P < .05). The Short-Form Health Survey indicated significant improvement post-treatment on the “Energy/Fatigue” and “Emotional Well Being” subscales. The intervention was rated by participants as acceptable and demonstrated high usability. This initial therapeutic treatment via videoconference offers promise to treat depression in older adults with neuropathy.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nursing (miscellaneous),Health Informatics
Reference43 articles.
1. Depression symptoms in patients with diabetic peripheral neuropathy;The Review of Diabetic Studies: RDS,2020
2. Chemotherapy-induced peripheral neuropathy onset is associated with early risk of depression and anxiety in breast cancer survivors;European Journal of Cancer Care,2022
3. Quality of life in painful peripheral neuropathies: a systematic review;Pain Research & Management,2019
4. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention;The Lancet Diabetes & Endocrinology,2019
5. Peripheral neuropathy fact sheet. Article;Peripheral Neuropathy,2018